サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1494319

北米のELISA診断検査：2030年市場予測-地域別分析-導入、検査タイプ、用途、エンドユーザー別

North America ELISA Diagnostics Tests Market Forecast to 2030 - Regional Analysis - by Adoption, Test Type, Application, and End User

出版日
ページ情報
英文 100 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.70円
北米のELISA診断検査：2030年市場予測-地域別分析-導入、検査タイプ、用途、エンドユーザー別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 100 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のELISA診断検査市場は、2022年に5億5,469万米ドルと評価され、2030年には10億956万米ドルに達すると予測され、2022～2030年のCAGRは7.8%で成長すると予測されています。

動物の感染症増加が北米ELISA診断検査市場を活性化

米国疾病予防管理センター（CDC）の報告書によると、動物や環境に関連した腸疾患は、米国だけで45万人の疾病、5,000人の入院、76人の死亡を引き起こしています。これらの病気は、動物の糞便や体液に接触した人間に見られるもので、動物との接触によって感染する病原体は人間にとって危険なものです。さらに、世界動物保健機構は、ヒトの感染症の60％が動物関連疾患であることを明らかにする報告書を発表しました。また、新興動物伝染病の75％がヒトに感染する可能性があり、毎年5つの新興動物伝染病が発生しています。WHOの報告書によれば、毎年、狂犬病感染に関連した医療請求が世界で約55,000件発生しており、その主要原因は、感染した犬に噛まれたことによる幼児たちです。さらに、Health for Animalsの報告書によれば、6つの動物関連疾患（ハンタウイルス、リンパ球性絨毛髄膜炎ウイルス（LCMV）、ペスト、サルモネラ菌、ネズミ咬傷熱、野兎病）が12年以内に800億米ドルの経済的損失をもたらしました。この6つのうち、動物に関連する病気は「口蹄疫」だけで、毎年世界で210億米ドルの損失を農業従事者に与えています。牛に見られる持続性リンパ球減少症（PL）は、妊娠中の子牛に感染する可能性があります。牛は深刻な乳量減少に苦しみ、周囲の他の動物に感染する可能性もあります。このような場合、酵素結合免疫吸着測定法（ELISA）検査は、検査時に適切なリンパ球数の臨床結果が得られるため、感染牛のPL病の陽性判定に最適です。さらに、この検査は獣医師により、感染後55日目の動物に対して95%の感度があると報告されています。従って、ELISA検査は一般的に8ヶ月齢以上の動物に獣医師から推奨されています。このように、動物関連疾患の発生率の上昇がELISA検査の需要を促進しています。

北米のELISA診断検査市場概要

ClinMed International Library 2017レポートによると、「ジアルジア腸炎」は米国で最も一般的な腸内寄生虫感染症です。さらに同国では、12歳以上の人口の22.5%が「トキソプラズマ・ゴンディ」に感染しています。さらに、過去20年間、米国では人獣共通感染症の発生率が上昇しており、米国人の感染症患者増加の重要な原因となっています。さらに、CDCの2023年報告書によると、2022年1月に米国で鳥インフルエンザ（AI）の発生率が上昇しました。CDCの報告によると、米国では59,031,321羽がAIの影響を受けたと述べています。そのため、米国でのAI感染をコントロールするために、陽性を確認するための市販のELISA検査キットが利用できるようになりました。このように、人獣共通感染症の多発によるヒトの感染症発生率の上昇が、米国におけるELISA診断検査の導入を後押ししています。

北米ELISA診断検査市場の収益と2030年までの予測（金額）

北米のELISA診断検査市場セグメンテーション

北米のELISA診断検査市場は、導入、検査タイプ、用途、エンドユーザー、国に基づいてセグメント化されます。導入に基づいて、北米のELISA診断検査市場はヒトと獣医に二分されます。2022年の市場シェアはヒト用が大きいです。

検査タイプでは、北米のELISA診断検査市場はサンドイッチELISA、間接ELISA、競合ELISA、マルチ＆ポータブルELISAに区分されます。間接ELISAセグメントが2022年に最大の市場シェアを占めました。

用途別では、北米のELISA診断検査市場は自己免疫疾患、感染症、がん診断、タンパク質定量、その他に区分されます。感染症セグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、北米ELISA診断検査市場は、病院＆診断センター、製薬＆バイオテクノロジー企業、動物病院＆診断ラボ、その他に区分されます。病院＆診断センターセグメントが2022年に最大の市場シェアを占めました。

国別では、北米のELISA診断検査市場は米国、カナダ、メキシコに区分されます。2022年の北米ELISA診断検査市場シェアは米国が独占しました。

Bio-Rad Laboratories Inc.、Idexx Laboratories Inc.、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Danaher Corp.、Pictor Ltd.、DiaSorin SpA、Elabscience Biotechnology Inc.、Bio-Techne Corp.は、北米ELISA診断検査市場で事業を展開する大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブ概要

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米ELISA診断検査市場：主要産業力学

  • 主要市場促進要因
    • 動物における感染症の増加
    • ヒトの感染症発生率の増加
  • 主要市場抑制要因
    • 製品回収の発生
  • 主要市場機会
    • 革新的な製品の上市
  • 今後の動向
    • ELISA法における進歩

第5章 ELISA診断検査市場：北米市場分析

  • イントロダクション
  • 北米のELISA診断検査市場売上高、2022～2030年

第6章 北米ELISA診断検査市場～2030年までの収益と予測：導入別

  • イントロダクション
  • 北米ELISA診断検査市場：2022年・2030年導入別売上高シェア（%）
  • ヒト
  • 動物

第7章 北米ELISA診断検査市場：検査タイプ別収益と2030年までの予測

  • イントロダクション
  • ELISA診断検査市場：2022年・2030年検査タイプ別売上高シェア（%）
  • サンドイッチELISA
  • 間接法ELISA
  • 競合ELISA
  • マルチプル＆ポータブルELISA

第8章 北米ELISA診断検査市場：用途別収益と2030年までの予測

  • イントロダクション
  • 北米ELISA診断検査市場：2022年・2030年用途別売上高シェア（%）
  • 自己免疫疾患
  • 感染症
  • がん診断
  • タンパク質定量
  • その他

第9章 北米ELISA診断検査市場：エンドユーザー別収益と2030年までの予測

  • イントロダクション
  • 北米ELISA診断検査市場：2022年・2030年エンドユーザー別売上高シェア（%）
  • 病院・診断センター
  • 製薬・バイオテクノロジー企業
  • 動物病院・診断ラボ
  • その他

第10章 北米のELISA診断検査市場：2030年までの収益と予測：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第11章 ELISA診断検査市場-業界情勢

  • イントロダクション
  • ELISA診断検査市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Bio-Rad Laboratories Inc
  • Idexx Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • Danaher Corp
  • Pictor Ltd
  • DiaSorin SpA
  • Elabscience Biotechnology Inc
  • Bio-Techne Corp

第13章 付録

図表

List Of Tables

  • Table 1. ELISA Diagnostic Test Market Segmentation
  • Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
  • Table 3. Following is a list of zoonotic disease outbreaks spread between animals and people.
  • Table 4. US ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Recent Organic Growth Strategies in ELISA diagnostics Test Market
  • Table 17. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
  • Table 18. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

  • Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
  • Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
  • Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
  • Figure 4. North America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
  • Figure 5. North America ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • Figure 6. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. North America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 26. US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Growth Strategies in ELISA diagnostics test Market
目次
Product Code: BMIRE00029814

The North America ELISA diagnostics tests market was valued at US$ 554.69 million in 2022 and is expected to reach US$ 1,009.56 million by 2030; it is estimated to grow at a CAGR of 7.8% from 2022 to 2030.

Rising Infectious Diseases Among Animals Fuel North America ELISA Diagnostics Tests Market

According to the Centers for Disease Control and Prevention (CDC) report, enteric diseases linked to animals or environments account for 450,000 case of illnesses, 5,000 hospitalizations, and 76 deaths among humans in the US alone. These illnesses are observed in humans in contact with animal feces or body fluids, and the pathogens transmitted through animal contact can prove dangerous for humans. Additionally, the World Organization for Animal Health published a report revealing that 60% of human infections comprise animal-related diseases. It also mentioned that 75% of emerging animal diseases can be transmitted to humans, and there are five emerging diseases among animals annually. Every year, about 55,000 healthcare claims are associated with rabies infection worldwide, comprising mainly children due to infected dog bites as per the WHO report. Further, the Health for Animals report reveals that six animal-related diseases (Hantavirus, Lymphocytic, Choriomeningitis virus (LCMV), plague, salmonella, rat bite fever, and tularemia) caused economic losses worth US$ 80 billion within 12 years. Among six, just one animal-related disease, "Foot and Mouth," costs farmers up to US$ 21 billion globally every year. The persistent lymphocytosis (PL) present among cows can infect their calves during pregnancy. Cows can suffer from serious milk production declines and may infect other surrounding animals. In this scenario, Enzyme-Linked Immunosorbent Assay (ELISA) test is best suited to test infected cow's positive for PL disease as it reveals proper lymphocyte count clinical results on testing. Further, the test is reported by veterinarian to be 95% sensitive for animals infected with 55 days of infection. Therefore, ELISA test is commonly recommended by veterinarian for animals aged 8 months and above. Thus, rising incidence of animal-associated diseases propels the demand for ELISA tests.

North America ELISA Diagnostics Tests Market Overview

The ClinMed International Library 2017 report reveals that "Giardia Intestinalis" is the most common intestinal parasitic infection in the US. Moreover, in the country, 22.5% of the population over 12 years of age gets infected with "Toxoplasma Gondii". Further, in the last two decades, there has been a rise in the incidence of zoonotic diseases in the US, becoming a significant cause of rising infectious disease cases among the US population. Additionally, the CDC 2023 report reveals that the incidence of avian influenza (AI) was on the rise in the US in January 2022. It stated that 59,031,321 birds were affected due to AI in the US as per the CDC report. Therefore, to control AI infections in the US, commercial ELISA test kits were made available to confirm any positives. Thus, rising incidences of infectious diseases among humans due to high zoonotic disease cases boost the adoption of ELISA diagnostic tests in the US.

North America ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

North America ELISA Diagnostics Tests Market Segmentation

The North America ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the North America ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the North America ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the North America ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the North America ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the North America ELISA diagnostics tests market is segmented into the US, Canada, and Mexico. The US dominated the North America ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the North America ELISA diagnostics tests market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation
    • 1.2.1 North America ELISA Diagnostic Tests Market - by Adoption
    • 1.2.2 North America ELISA Diagnostic Tests Market - by Test Type
    • 1.2.3 North America ELISA Diagnostic Tests Market - by Application
    • 1.2.4 North America ELISA Diagnostic Tests Market - by End User
    • 1.2.5 North America ELISA Diagnostic Tests Market - by Country

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America ELISA Diagnostic Test Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Infectious Diseases Among Animals
    • 4.1.2 Increasing Incidence of Human Infections
  • 4.2 Key Market Restraints
    • 4.2.1 Incidents of Product Recalls
  • 4.3 Key Market Opportunities
    • 4.3.1 Innovative Product Launches
  • 4.4 Future Trends
    • 4.4.1 Advancements in ELISA-Based Procedures

5. ELISA Diagnostic Tests Market - North America Market Analysis

  • 5.1 Overview
  • 5.2 North America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

6. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

  • 6.1 Overview
  • 6.2 North America ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • 6.3 Human
    • 6.3.1 Overview
    • 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Veterinary
    • 6.4.1 Overview
    • 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

7. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Sandwich ELISA
    • 7.3.1 Overview
    • 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Indirect ELISA
    • 7.4.1 Overview
    • 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Competitive ELISA
    • 7.5.1 Overview
    • 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Multiple & Portable ELISA
    • 7.6.1 Overview
    • 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Autoimmune Diseases
    • 8.3.1 Overview
    • 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Cancer Diagnosis
    • 8.5.1 Overview
    • 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Protein Quantification
    • 8.6.1 Overview
    • 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 North America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals & Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical & Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Veterinary Hospitals & Diagnostic Laboratories
    • 9.5.1 Overview
    • 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 North America: ELISA Diagnostic Tests Market
    • 10.1.1 North America: ELISA Diagnostic Tests Market, by Country
      • 10.1.1.1 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

11. ELISA Diagnostics Test Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in ELISA diagnostics test Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Bio-Rad Laboratories Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Idexx Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Thermo Fisher Scientific Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Abbott Laboratories
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Danaher Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Pictor Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 DiaSorin SpA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Elabscience Biotechnology Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Financial Overview
    • 12.9.4 SWOT Analysis
    • 12.9.5 Key Developments
  • 12.10 Bio-Techne Corp
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms